This biotech name is evolving into a major obesity play. How to trade it with options
- Posted on December 17, 2025
- By CNBC
- 2 Views
This biotech name is evolving into a major obesity play. How to trade it with options
Key catalysts, including growing confidence around Amgen’s MariTide obesity program, could transform the name into a growth story.
